H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.3% of adults in Albuquerque have diagnosed diabetes — 0.7 points below the U.S. 12% figure. Census population 564,559. New Mexico Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Albuquerque clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Albuquerque storefront.
Biologic Therapy for Osteoarthritis in Albuquerque, NM for clinics & physicians. Biologic therapy options… Compliance support & pricing — contact Hawk Medical.
Albuquerque is a city of 500k–1M (564,559 Census). CDC PLACES (2023, crude) estimates 11.3% of adults in Albuquerque have diagnosed diabetes — 0.7 points below the U.S. 12% figure. Adult arthritis here is 24.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Biologic Therapy for Osteoarthritis notes (how the product actually works)JH reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Albuquerque is 11.3% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 14.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 11.3% of adults — 0.7 points below the U.S. 12% figure. Obesity is 32.9%; arthritis is 24.2%. That is place-level BRFSS modeling, not a clinic census and not a Albuquerque trial.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
If you operate in New Mexico and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Albuquerque tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Albuquerque, NM.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Albuquerque is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Albuquerque — 0.7 points below the U.S. 12% figure. Planning input, not an outcomes claim.
New Mexico Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, OK, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Albuquerque. Useful for joint-program math; still needs a diagnosis and privileging.
No Albuquerque storefront. Joe Bradley is an active practice owner. osteoarthritis biologic therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.